China First: RuiYi Takes Exclusive License To arGEN-X’s Anti-IL6 Antibody
This article was originally published in The Pink Sheet Daily
Executive Summary
The China/U.S.-based company RuiYi is to develop an anti-IL6 antibody licensed from Belgium’s arGEN-X first in China.